Found: 5
Select item for more details and to access through your institution.
Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatment.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02225-w
- By:
- Publication type:
- Article
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 509, doi. 10.3390/cancers11040509
- By:
- Publication type:
- Article
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 7, p. 2427, doi. 10.1007/s10620-020-06533-7
- By:
- Publication type:
- Article
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease.
- Published in:
- Gut & Liver, 2024, v. 18, n. 2, p. 294, doi. 10.5009/gnl220409
- By:
- Publication type:
- Article
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence.
- Published in:
- Gut & Liver, 2022, v. 16, n. 3, p. 414, doi. 10.5009/gnl210062
- By:
- Publication type:
- Article